Viatris Inc (VTRS)
Every FINRA and SEC series the site collects for Viatris Inc: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
38.6M
Short interest
settlement 2026-08-31
5.3
Days to cover
+4.3% vs prior
35.8%
Short share of volume
2026-09-11
744
Fails to deliver
settlement 2026-08-10
-$810K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in VTRS is 38,610,690 shares, down 7,076,799 shares over the last month. Over the last 48 readings it ranged from 20,597,769 shares (29 November 2024) to 51,688,103 shares (15 May 2025). At the reported average volume of 7.2M shares a day that is 5.3 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/vtrs" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 38,610,690 | +4.3% | 7,230,642 | 5.34 |
| 2026-08-14 | 37,018,623 | -19.0% | 12,496,498 | 2.96 |
| 2026-07-31 | 45,687,489 | -3.2% | 9,514,726 | 4.80 |
| 2026-07-15 | 47,215,480 | -1.7% | 9,082,186 | 5.20 |
| 2026-06-30 | 48,017,941 | +6.6% | 10,848,780 | 4.43 |
| 2026-06-15 | 45,050,829 | +9.6% | 8,882,571 | 5.07 |
| 2026-05-29 | 41,119,380 | +7.9% | 10,482,013 | 3.92 |
| 2026-05-15 | 38,107,135 | +0.9% | 15,454,665 | 2.47 |
| 2026-04-30 | 37,783,688 | +7.2% | 10,941,398 | 3.45 |
| 2026-04-15 | 35,245,951 | +9.7% | 7,538,926 | 4.68 |
| 2026-03-31 | 32,122,224 | +13.4% | 9,739,652 | 3.30 |
| 2026-03-13 | 28,323,140 | +0.2% | 11,934,307 | 2.37 |
| 2026-02-27 | 28,258,520 | +6.8% | 11,190,798 | 2.53 |
| 2026-02-13 | 26,450,946 | -5.0% | 11,534,020 | 2.29 |
| 2026-01-30 | 27,832,542 | +10.1% | 7,184,245 | 3.87 |
| 2026-01-15 | 25,272,723 | +15.1% | 9,643,036 | 2.62 |
| 2025-12-31 | 21,954,908 | -21.4% | 9,173,693 | 2.39 |
| 2025-12-15 | 27,940,439 | +6.4% | 7,437,734 | 3.76 |
| 2025-11-28 | 26,256,419 | +12.0% | 7,492,948 | 3.50 |
| 2025-11-14 | 23,450,669 | -9.8% | 11,177,228 | 2.10 |
| 2025-10-31 | 25,985,671 | -9.9% | 7,075,206 | 3.67 |
| 2025-10-15 | 28,840,371 | -6.4% | 7,446,123 | 3.87 |
| 2025-09-30 | 30,804,678 | -26.3% | 12,361,534 | 2.49 |
| 2025-09-15 | 41,796,330 | +3.1% | 9,972,383 | 4.19 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of VTRS volume is 35.8%, down 30.1 points over the last five sessions. Over the last 52 readings it ranged from 35.8% (11 September 2026) to 73.5% (15 July 2026). The latest reading sits at the bottom of that range. The latest reading is 20.2 points below the 30-session average of 56.0%, on 4.0M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 1.4M | 4.0M | 35.8% | 27,775 |
| 2026-09-10 | 1.6M | 3.4M | 46.1% | 1,958 |
| 2026-09-09 | 1.3M | 2.2M | 57.4% | 17,814 |
| 2026-09-08 | 1.1M | 1.6M | 64.8% | 304 |
| 2026-09-04 | 908K | 1.4M | 65.5% | 2,629 |
| 2026-09-03 | 1.6M | 2.4M | 65.9% | 164 |
| 2026-09-02 | 1.3M | 2.3M | 56.9% | 25,176 |
| 2026-09-01 | 1.6M | 2.5M | 67.2% | 1,697 |
| 2026-08-31 | 1.6M | 2.7M | 60.8% | 3,563 |
| 2026-08-28 | 1.6M | 2.5M | 63.2% | 132 |
| 2026-08-27 | 1.3M | 2.3M | 53.2% | 4,775 |
| 2026-08-26 | 1.1M | 2.5M | 45.3% | 1,000 |
| 2026-08-25 | 1.1M | 2.1M | 50.5% | 45 |
| 2026-08-24 | 1.2M | 2.1M | 55.9% | 290 |
| 2026-08-21 | 1.1M | 2.3M | 49.3% | 3,867 |
| 2026-08-20 | 956K | 2.1M | 45.9% | 9 |
| 2026-08-19 | 1.1M | 1.9M | 54.6% | 827 |
| 2026-08-18 | 1.5M | 3.3M | 46.5% | 2,993 |
| 2026-08-17 | 1.6M | 3.0M | 53.4% | 2,841 |
| 2026-08-14 | 1.8M | 3.0M | 61.3% | 250 |
| 2026-08-13 | 2.6M | 4.7M | 56.0% | 59 |
| 2026-08-12 | 1.9M | 3.0M | 62.8% | 303 |
| 2026-08-11 | 2.5M | 4.1M | 59.5% | 793 |
| 2026-08-10 | 3.0M | 5.2M | 57.7% | 1,667 |
| 2026-08-07 | 3.4M | 5.5M | 62.0% | 1,151 |
| 2026-08-06 | 5.2M | 7.8M | 67.2% | 47,091 |
| 2026-08-05 | 1.8M | 3.0M | 61.0% | 2,465 |
| 2026-08-04 | 1.3M | 2.7M | 49.4% | 57 |
| 2026-08-03 | 1.6M | 2.9M | 54.2% | 850 |
| 2026-07-31 | 1.1M | 2.2M | 51.1% | 12,358 |
Fails to deliver
SEC, by settlement date. JSONAs of 10 August 2026, the fails-to-deliver balance in VTRS is 744 shares, up 714 shares over the last settlement date. Over the last 52 readings it ranged from 9 shares (15 April 2026) to 175,000 shares (4 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-10 | 744 | $16.43 | $12K |
| 2026-08-07 | 30 | $16.29 | $489 |
| 2026-08-06 | 3,968 | $17.65 | $70K |
| 2026-08-05 | 4,768 | $17.70 | $84K |
| 2026-08-04 | 175,000 | $17.63 | $3.1M |
| 2026-07-29 | 50 | $17.86 | $893 |
| 2026-07-23 | 86,292 | $17.01 | $1.5M |
| 2026-07-22 | 6,805 | $17.59 | $120K |
| 2026-07-20 | 36,289 | $17.29 | $627K |
| 2026-07-17 | 621 | $17.33 | $11K |
| 2026-07-15 | 6,505 | $16.31 | $106K |
| 2026-07-09 | 338 | $16.66 | $6K |
| 2026-07-07 | 480 | $16.80 | $8K |
| 2026-07-06 | 468 | $16.70 | $8K |
| 2026-06-30 | 948 | $16.23 | $15K |
| 2026-06-26 | 875 | $16.07 | $14K |
| 2026-06-24 | 52,958 | $15.75 | $834K |
| 2026-06-23 | 3,789 | $15.38 | $58K |
| 2026-06-22 | 500 | $15.37 | $8K |
| 2026-06-18 | 10,408 | $15.73 | $164K |
| 2026-06-16 | 3,072 | $16.32 | $50K |
| 2026-06-15 | 4,118 | $16.48 | $68K |
| 2026-06-11 | 23 | $15.77 | $363 |
| 2026-06-08 | 4,814 | $15.88 | $76K |
| 2026-06-05 | 2,165 | $15.90 | $34K |
| 2026-06-03 | 10 | $15.69 | $157 |
| 2026-06-02 | 2,366 | $15.81 | $37K |
| 2026-06-01 | 78,523 | $16.26 | $1.3M |
| 2026-05-29 | 2,943 | $16.11 | $47K |
| 2026-05-27 | 64 | $16.26 | $1K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at VTRS reported 1 open-market sell worth $810K in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Enrietti Andrew (See Remarks) on 2026-08-15.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-15 | Enrietti Andrew | See Remarks | Tax withholding | 435 | $16.23 | $7K | 234K |
| 2026-08-15 | Enrietti Andrew | See Remarks | Option exercise | 999 | $0.00 | $0 | 235K |
| 2026-08-15 | Enrietti Andrew | See Remarks | Tax withholding | 11K | $16.23 | $177K | 234K |
| 2026-08-15 | Enrietti Andrew | See Remarks | Option exercise | 25K | $0.00 | $0 | 245K |
| 2026-06-25 | Campbell Paul | See Remarks | Sell | 50K | $16.17 | $810K | 316K |
| 2026-04-15 | Le Goff Corinne | Chief Commercial Officer | Tax withholding | 2K | $13.86 | $22K | 107K |
| 2026-04-15 | Le Goff Corinne | Chief Commercial Officer | Option exercise | 4K | $0.00 | $0 | 109K |
| 2026-04-15 | Le Goff Corinne | Chief Commercial Officer | Tax withholding | 17K | $13.86 | $242K | 105K |
| 2026-04-15 | Le Goff Corinne | Chief Commercial Officer | Option exercise | 39K | $0.00 | $0 | 123K |
| 2026-03-23 | Campbell Paul | See Remarks | Sell | 21K | $13.28 | $284K | 366K |
| 2026-03-06 | Vivaldi Coelho Rogerio | n/a | Option exercise | 1K | $0.00 | $0 | 47K |
| 2026-03-06 | Vivaldi Coelho Rogerio | n/a | Option exercise | 24K | $0.00 | $0 | 45K |
| 2026-03-06 | Smith Scott Andrew | Chief Executive Officer | Tax withholding | 2K | $14.16 | $34K | 1.3M |
| 2026-03-06 | Smith Scott Andrew | Chief Executive Officer | Option exercise | 6K | $0.00 | $0 | 1.3M |
| 2026-03-06 | Smith Scott Andrew | Chief Executive Officer | Tax withholding | 49K | $14.16 | $694K | 1.3M |
| 2026-03-06 | Smith Scott Andrew | Chief Executive Officer | Option exercise | 125K | $0.00 | $0 | 1.4M |
| 2026-03-06 | SIMMONS DAVID S | n/a | Option exercise | 524 | $0.00 | $0 | 23K |
| 2026-03-06 | SIMMONS DAVID S | n/a | Option exercise | 23K | $0.00 | $0 | 23K |
| 2026-03-06 | SEVERINO MICHAEL | n/a | Option exercise | 919 | $0.00 | $0 | 26K |
| 2026-03-06 | SEVERINO MICHAEL | n/a | Option exercise | 25K | $0.00 | $0 | 25K |
| 2026-03-06 | PARRISH MARK W | n/a | Option exercise | 1K | $0.00 | $0 | 165K |
| 2026-03-06 | PARRISH MARK W | n/a | Option exercise | 24K | $0.00 | $0 | 164K |
| 2026-03-06 | Mistras Theodora | Chief Financial Officer | Tax withholding | 1K | $14.16 | $16K | 71K |
| 2026-03-06 | Mistras Theodora | Chief Financial Officer | Option exercise | 2K | $0.00 | $0 | 72K |
| 2026-03-06 | Mistras Theodora | Chief Financial Officer | Tax withholding | 23K | $14.16 | $327K | 70K |
| 2026-03-06 | Mistras Theodora | Chief Financial Officer | Option exercise | 42K | $0.00 | $0 | 93K |
| 2026-03-06 | MARK RICHARD A | n/a | Option exercise | 1K | $0.00 | $0 | 116K |
| 2026-03-06 | MARK RICHARD A | n/a | Option exercise | 24K | $0.00 | $0 | 115K |
| 2026-03-06 | Lyons Dillon JoEllen | n/a | Option exercise | 1K | $0.00 | $0 | 103K |
| 2026-03-06 | Lyons Dillon JoEllen | n/a | Option exercise | 24K | $0.00 | $0 | 101K |
| 2026-03-06 | Le Goff Corinne | Chief Commercial Officer | Tax withholding | 973 | $14.16 | $14K | 83K |
| 2026-03-06 | Le Goff Corinne | Chief Commercial Officer | Option exercise | 2K | $0.00 | $0 | 84K |
| 2026-03-06 | Le Goff Corinne | Chief Commercial Officer | Tax withholding | 20K | $14.16 | $277K | 82K |
| 2026-03-06 | Le Goff Corinne | Chief Commercial Officer | Option exercise | 44K | $0.00 | $0 | 102K |
| 2026-03-06 | KILTS JAMES M | n/a | Option exercise | 1K | $0.00 | $0 | 161K |
| 2026-03-06 | KILTS JAMES M | n/a | Option exercise | 24K | $0.00 | $0 | 160K |
| 2026-03-06 | HIGGINS MELINA E | n/a | Option exercise | 1K | $0.00 | $0 | 146K |
| 2026-03-06 | HIGGINS MELINA E | n/a | Option exercise | 24K | $0.00 | $0 | 145K |
| 2026-03-06 | Groothuis Leo Frans | n/a | Tax withholding | 62 | $14.16 | $878 | 63K |
| 2026-03-06 | Groothuis Leo Frans | n/a | Option exercise | 1K | $0.00 | $0 | 63K |
| 2026-03-06 | Groothuis Leo Frans | n/a | Tax withholding | 1K | $14.16 | $18K | 62K |
| 2026-03-06 | Groothuis Leo Frans | n/a | Option exercise | 24K | $0.00 | $0 | 64K |
| 2026-03-06 | FINNEY ELISHA W | n/a | Option exercise | 1K | $0.00 | $0 | 63K |
| 2026-03-06 | FINNEY ELISHA W | n/a | Option exercise | 24K | $0.00 | $0 | 61K |
| 2026-03-06 | Enrietti Andrew | See Remarks | Tax withholding | 415 | $14.16 | $6K | 220K |
| 2026-03-06 | Enrietti Andrew | See Remarks | X | 952 | $0.00 | $0 | 220K |
| 2026-03-06 | Enrietti Andrew | See Remarks | Tax withholding | 8K | $14.16 | $118K | 219K |
| 2026-03-06 | Enrietti Andrew | See Remarks | X | 19K | $0.00 | $0 | 227K |
| 2026-03-06 | DAMELIO FRANK A | n/a | Option exercise | 919 | $0.00 | $0 | 26K |
| 2026-03-06 | DAMELIO FRANK A | n/a | Option exercise | 25K | $0.00 | $0 | 25K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON6 holders above 5% have filed on VTRS, all on Schedule 13G (passive). The largest reported stake is FMR LLC at 11.0% of the class (126,764,446 shares), filed 2026-09-08 for an event on 2026-08-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-09-08 | 13G/Ano. 1 | FMR LLCparent holding company | 126.8M | 11.0% | 2026-08-31 |
| 2026-09-08 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 126.8M | 11.0% | 2026-08-31 |
| 2026-08-12 | 13G/Ano. 8 | DAVIS SELECTED ADVISERSinvestment adviser | 75.2M | 6.5% | 2026-06-30 |
| 2026-08-06 | 13G | FMR LLCparent holding company | 96.4M | 8.3% | 2026-06-30 |
| 2026-08-06 | 13G | Abigail P. Johnsonindividual | 96.4M | 8.3% | 2026-06-30 |
| 2026-05-05 | 13G/Ano. 7 | DAVIS SELECTED ADVISERSinvestment adviser | 78.2M | 6.8% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 84.8M | 7.4% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 3 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-04 | 13G/Ano. 6 | DAVIS SELECTED ADVISERSinvestment adviser | 78.2M | 6.1% | 2025-12-31 |
| 2025-11-10 | 13G/Ano. 5 | DAVIS SELECTED ADVISERSinvestment adviser | 69.3M | 6.7% | 2025-09-30 |
| 2025-10-17 | 13G/Ano. 4 | BlackRock, Inc.parent holding company | 76.4M | 6.6% | 2025-09-30 |
13F holders
Tracked managers holding VTRS at their latest 13F. JSON8 of the 30 tracked managers held VTRS at their latest 13F, $199.6M in total at quarter-end prices. AQR Capital Management is the largest at $74.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 4.7M | $74.6M | 0.03% | -1.6M |
| Greenlight Capital (DME Capital) | 2026-06-30 | 2.8M | $44.0M | 1.13% | +956K |
| Bridgewater Associates | 2026-06-30 | 1.7M | $27.0M | 0.11% | +972K |
| Citadel Advisors | 2026-06-30 | 1.4M | $22.3M | 0.00% | -3.9M |
| D. E. Shaw & Co. | 2026-06-30 | 791K | $12.6M | 0.01% | -3.1M |
| Point72 Asset Management | 2026-06-30 | 623K | $9.9M | 0.01% | -1.2M |
| Millennium Management | 2026-06-30 | 314K | $5.0M | 0.00% | -2.5M |
| Two Sigma Investments | 2026-06-30 | 271K | $4.3M | 0.00% | +70K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) Viatris Inc reported revenue of $3.75B, up 5.0% from the same quarter a year earlier (-0.10 diluted EPS). In FY 2025 it generated $2.32B of operating cash flow and spent $500.5M on buybacks. As of 2026-06-30, cash was $886.5M against $13.35B of debt.
- Cash
- $886.5M
- Debt
- $13.35B
- Total assets
- $35.04B
- Shares outstanding
- 1,148,590,864
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.75B | n/a | n/a | -0.10 |
| Q1 2026 | 2026-03-31 | $3.51B | n/a | n/a | 0.15 |
| Q4 2025derived | 2025-12-31 | $3.69B | n/a | n/a | n/a |
| Q3 2025 | 2025-09-30 | $3.75B | n/a | n/a | -0.11 |
| Q2 2025 | 2025-06-30 | $3.57B | n/a | n/a | 0.00 |
| Q1 2025 | 2025-03-31 | $3.24B | n/a | n/a | -2.55 |
| Q4 2024derived | 2024-12-31 | $3.52B | n/a | n/a | n/a |
| Q3 2024 | 2024-09-30 | $3.74B | n/a | n/a | 0.08 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $14.25B | n/a | $2.32B | $378.8M | $500.5M | n/a |
| FY 2024 | 2024-12-31 | $14.69B | n/a | $2.30B | $326.0M | $250.0M | n/a |
| FY 2023 | 2023-12-31 | $15.39B | n/a | $2.90B | $377.0M | $250.0M | n/a |
| FY 2022 | 2022-12-31 | $16.22B | n/a | $3.00B | $406.0M | $0 | n/a |
| FY 2021 | 2021-12-31 | $17.81B | n/a | $3.02B | $457.2M | $0 | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-03 from the cover page.
What this page is
Viatris Inc in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Viatris Inc (VTRS), SEC CIK 1792044, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-10.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-09-08.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-15.JSON and CSV
- Company record
- EDGAR filing index for CIK 1792044Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 14 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
- UTHRUNITED THERAPEUTICS Corp
- CPIXCUMBERLAND PHARMACEUTICALS INC
- REGNREGENERON PHARMACEUTICALS, INC.
- LLYELI LILLY & Co
- VRTXVERTEX PHARMACEUTICALS INC / MA
- ALNYALNYLAM PHARMACEUTICALS, INC.
- BMYBRISTOL MYERS SQUIBB CO
- CYTKCYTOKINETICS INC
- PTCTPTC THERAPEUTICS, INC.
- INSMINSMED Inc
- IONSIONIS PHARMACEUTICALS INC
- MDGLMADRIGAL PHARMACEUTICALS, INC.
- JNJJOHNSON & JOHNSON
- CORTCORCEPT THERAPEUTICS INC
- ABBVAbbVie Inc.
- ROIVRoivant Sciences Ltd.
- ABTABBOTT LABORATORIES
- BBIOBridgeBio Pharma, Inc.
- KNSAKiniksa Pharmaceuticals International, plc
- JAZZJazz Pharmaceuticals plc
- ARQTArcutis Biotherapeutics, Inc.
- PRGOPERRIGO Co plc
- DYNDyne Therapeutics, Inc.
- ARDXARDELYX, INC.
Datasets
Frequently Asked Questions
How much of VTRS is sold short?
What is VTRS's daily short volume?
Does VTRS have fails to deliver?
Are VTRS insiders buying or selling?
Who owns more than 5% of VTRS?
What did VTRS report last quarter?
Which funds hold VTRS?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.